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variety of structures [1]. Non-ribosomally generated amphi-
pathic lipopeptide antibiotics with condensed β-hydroxyl or 
β-amino fatty acids are widespread in B. subtilis [2]. These 
are synthesized by large multienzyme systems that have 
a modular structure [3]. Lipopeptide antibiotics identified 
so far have been divided into three main groups according 
to their structure: surfactin group, iturin group, and fengy-
cin group [4]. All these agents occur as families of closely 
related isoforms which differ in length and branching of the 
fatty acid side chains and in amino-acid substitutions in the 
peptide rings [5]. These agents are natural compounds with 
a high potential for biotechnological and pharmaceutical 
applications [6]. They are distinguished by excellent surface 
and membrane-active properties along with superior emulsi-
fying and foaming properties [7], which can be utilized in 
food biotechnology and in the agricultural sector. Apart from 
this, bioactive lipopeptides act as antifungal agents [8], anti-
viral agents, antiameobocytic agents, and antimycoplasma 
agents [9]. Surfactin is well qualified to maintain virus and 
mycoplasma safety in biotechnological products [10]. Their 
mechanism of action is ongoing and has revealed even inter-
cellular mechanisms [11]. Lipopeptides are often extracted 
from culture broth by classical methods, including acidic 
precipitation (HCl), recrystallization, and extraction by 
organic solvents. Unfortunately, impurities are coextracted 
and the extraction must be completed by the chromato-
graphic procedures [12]. Therefore, to purify and concen-
trate lipopeptides, several authors have attempted one-step 
methods [13], including a two-phase extraction [14], an 
ultrafiltration method [15], and a solid-phase extraction [16]. 
The technique of foam fractionation is also of great inter-
est, as it offers the double advantage of continuous in situ 
removal of surfactin from the fermentation broth and pre-
vention of any possible feed-back inhibition [17]. A Bacil-
lus strain, designated as BIA exhibiting antibacterial activity, 
Abstract Bacillus subtilis strain BIA was used for the pro-
duction of bioactive lipopeptides. Different extraction and 
purificationmethods were assayed as liquid–liquid extrac-
tion, and acid and ammonium sulfate precipitation followed 
by TLC, SPE, and gel filtration. Active fractions were further 
purified using RP-HPLC. The molecular mass of the purified 
product from HPLC was determined through Tris-Tricine 
SDS-PAGE and MALDI–TOF-MS. The results revealed that 
Bacillus subtilis strain BIA produced surfactin and iturin like 
compounds. Coproduction of surfactin and iturin like com-
pounds by this strain is a remarkable trait for a potential bio-
control agent. This paper also includeds techniques that have 
been developed for the optimal and convenient extraction of 
bioactive lipopeptides from microbial origin.
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Introduction
Several hundred wild-type Bacillus spp. have the potential 
to produce more than two dozen antibiotics with an amazing 
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was isolated from Pakistan with spectrum of activity mostly 
against Gram-positive bacteria. The strain was identified on 
the basis of 16S rRNA and biochemical characterization. 
Lipopeptide analysis was performed by Tris-Tricine SDS-
PAGE and matrix-assisted laser desorption ionization–time 
of flight-mass spectrometry (MALDI–TOF-MS). The results 
from Tris-Tricine SDS-PAGE showed that B. subtilis BIA 
produces an antibacterial compound with molecular mass 
of about 3 kDa. The exact molecular mass was determined 
through MALDI–TOF-MS which is effective for peptides 
and proteins with molecular masses ranging from 0.5 to 
30 kDa. Here, we report the co-production of surfactin and 
iturin like compounds from B. subtilis BIA based on their 
molecular masses through MALDI–TOF-MS.
Materials and Methods
Bacterial Strains and Culture Conditions
Twenty-four strains isolated from different soil samples 
were tested for their antibiotic production using the agar-
well diffusion assay [18]. One strain was selected based 
upon the size and clarity of zone of inhibition. The test 
organisms are a collection of laboratory strains as well as 
environmental isolates. Bacillus fusiformis was routinely 
used for the sensitivity tests. All strains were routinely 
maintained on nutrient agar [19], however, for antibiotic 
production Landy medium [20] was used.
Antibiotic Assay
Samples of culture supernatant containing the antibiotic 
were assayed for activity using an agar-well diffusion assay 
[18]. Fifty microliter of Bacillus fusiformis liquid culture 
of 0.3 OD600 was spread onto the surface of Petri dish-con-
taining l-agar. 50 μL antibiotic sample was transferred into 
the well made in media plates using a sterile cork borer. The 
sample was allowed to diffuse into the agar and the plate was 
inverted and incubated at 37 °C until a lawn of the indicator 
bacteria appeared on the plate (approximately 10–16 h).
DNA Extraction PCR and Ribotyping
Genomic DNA was extracted from overnight incu-
bated bacterial culture in Luria–Bertani LB-broth [19] 
at 37 °C with 120 rpm. The extraction was carried out 
using gene extraction kit (Biorad, UK). PCR amplifica-
tion of 16S rDNA was performed successfully following 
the method described by [21] with forward primer 27f 
(5-AGAGTTTGATCCTGGCTCAG) and reverse primer 
1522r (5-AAGGAGGTGATCCA(AG)CCGCA) [22]. To 
0.5–0.1 ng of chromosomal template DNA, 0.25 μM each 
primer, 200 μM deoxynucleoside triphosphate, and 1 unit 
of Taq polymerase were added. Solution was heated to 
94 °C for 5 min and passed through 29 cycles as follows: 
denaturation for 20 s at 94 °C, primer annealation for 20 s 
at 50 °C, and extension at 72 °C for 2 min. Final exten-
sion was at 72 °C for 5 min. The product was purified using 
Aqua pure extraction kit (Fermantas, UK) and sequenced 
using both 27f and 1522r primers by automatic sequencer 
(Applied Biosystems, USA).
Solvent Extraction and Thin‑Layer Chromatography 
Analysis
Bacterial supernatant, recovered by 15,000×g centrifugation 
for 20 min of 36-h old shaken culture, was screened for the 
presence of active compounds. Supernatants were extracted 
with same amount ethyl acetate (Fishers, USA) and vacuum 
dried. Residues were dissolved in minimal amount of ethyl 
acetate and subjected to thin-layer chromatography (TLC) 
sheet (Merck, Germany) and developed with 1:1:1 v/v/v of 
n-hexane, chloroform, and methanol as mobile phase. The 
spots were detected under UV light; by spraying with water 
for the detection of hydrophilic compounds; with ninhydrin 
for detection of compound with free amino groups [23, 24]. 
However, active fractions were detected using a narrow strip 
of developed sheets by a bioassay method with a sensitive 
test organism [13]. The active fraction was scrapped from 
the TLC plate and extracted with eluent A (0.1 % (vol/vol) 
trifluoroacetic acid and 20 % (vol/vol) acetonitrile).
Acid Precipitation and Solid‑Phase Extraction
Lipopeptides (LPS) were precipitated with 12-N HCl (pH 
2.0) and the precipitate was extracted with minimal amount 
of methanol. The sample was dried and dissolved in 20 % 
(vol/vol) acetonitrile. This sample was fractionated through 
solid-phase extraction (SPE) columns (CHROMABOND 
C18ec) purchased from Macherey–Nagel, Germany. First 
columns were preconditioned with methanol then water 
and samples were applied under low pressure. The columns 
were washed with water and seven fractions were eluted 
by consecutive seven solutions 5, 15, 25, 35, 50, 75, and 
100 % acetonitrile. The active fractions were monitored 
through the spot-plate method using test organism.
Ammonium Sulfate Precipitation (ASP) and Gel 
Filtration Chromatography
Ammonium sulfate (Sigma) was gently added to the cell-
free supernatant (maintained at 4 °C) to obtain 80 % sat-
uration, and stirred for 4 h. After centrifugation (1 h at 
20,000×g, 4 °C), the pellet was resuspended in 50-mM 
Tris–HCl, pH 7.5, and loaded on Econo-Pac 10DG column 
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(Biorad, UK) equilibrated in 50 mM Tris–HCl, pH 7.5. The 
lipopeptides were eluted from the column using a flow rate 
of 0.5 mL/min and fractions were collected every 1 mL. 
The similar fractions evaluated by TLC were combined and 
tested for their antimicrobial activity by agar-well diffusion 
assay.
Purification by Reverse Phase HPLC
Active fractions from TLC, SPE, and gel filtration were 
further purified by reversed-phase HPLC using Thermo 
Hypersil-Keystone ODS (particle size, 5 μm; column 
dimensions, 250 by 4.6 mm, Thermo Hypersil, USA). The 
sample was applied along with eluent A (Milli-Q HPLC 
grad water) and eluted with segmented gradients of eluent 
B (0.1 % vol/vol trifluoroacetic acid and acetonitrile). The 
system used was 40 % eluent B for 30 min and 40–100 % 
eluent B for 10 min.
Tris‑Tricine SDS‑PAGE
Gel electrophoresis was performed according to the 
method of Schagger [25]. Tris-Tricine SDS-PAGE gels 
were made and run using a Mini Protean II slab gel elec-
trophoresis unit (Biorad). One millimeter spacers were 
used to set the thickness of the gels. Each gel consisted of 
two portions: a 2-cm stacking gel, and a 5.0-cm separating 
gel. Culture supernatant samples were lyophilized and dis-
solved in loading buffer prior to PAGE. The purified anti-
biotic was dissolved directly in loading buffer. Gels were 
run at 40 V until the tracking dye passed stacking gel, and 
then, a constant voltage of 140 V was applied until the dye 
reached the bottom of the gel. Gels were visualized by 
staining with coomassie brilliant blue. Antibiotic activity 
was specifically located on the gel using a direct activity 
assay [26].
MALDI–TOF‑Mass Spectrometry Analysis
Purified compound from RP-HPLC was analyzed through 
matrix assistant laser desorption ionization time of flight-
mass spectroscopy (MALDI–TOF-MS) to find the exact 
molecular mass. 2 µL of sample mixed with 2-µL matrix 
solution (2 mg of alpha-cyano-4-hydroxycinnaminic acid 
per ml in acetonitrile-methanol–water (1:1:1) on the tar-
get plate). MALDI–TOF-MS spectra were recorded using 
a 337-nm nitrogen laser for desorption and ionization. The 
mass spectrometer was operated in the linear mode at an 
accelerating voltage of 18 kV with an ion flight path that 
was 0.7-m long. The delay time was 375 ns. Matrix sup-
pression was also used, and the mass spectra were averaged 
over 50–100 individual laser shots. The laser intensity was 
set just above the threshold for ion production. External 
calibration was performed using the [M + H]+ signals of 
renin, adrenocorticotropic hormone, insulin oxidized B, 
and bovine insulin (Sigma-Aldrich Co.).
Results
16S rDNA Sequence Analysis and Phylogeny
Bacillus subtilis strain BIA was identified on the basis 
of the 16S rDNA sequence analysis. For that purpose, 
nearly complete 16S rDNA sequence was determined 
and analyzed using NCBI Website. Strain BIA showed 
more than 97 % homology with B. subtilis strain B-FS01 
(DQ520955).
Thin‑Layer Chromatography
Eight prominent spots were visible under UV having Rf val-
ues of 0.08, 0.12, 0.21, 0.37, 0.49, 0.53, and 0.57. However, 
only one active fraction was observed upon bioassay with 
Rf value of 0.49. The spot was ninhydrin negative, indi-
cating the absence of free amino groups and presence of 
peptide bonds in the compound. A white spot formed with 
same Rf value when the plate was sprayed with water, indi-
cating that the compound is lipophilic. In addition, spots 
with Rf values of 0.08 and 0.53 could not be stained with 
ninhydrin, while all other spots were ninhydrin positive.
Solid‑Phase Extraction
Seven fractions were collected by decreasing the polarity 
with acetonitrile until 100 % and tested for activity. Frac-
tions eluted with 5, 15, 25, and 35 % acetonitrile did not 
show any activity. However, three active fractions were 
eluted with 50, 75, and 100 % acetonitrile with peak activ-
ity at 75 % (Fig. 1), showing that maximum product is 


















Fig. 1  Solid-phase extraction from the acid precipitation of culture 
supernatant. Seven fractions were eluted with decreasing polarity and 
activity observed using sensitive test organism
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Gel Filtration Chromatography
The sample eluted from the column at two distinct peaks 
(Fig. 2). Initially high-molecular weight components were 
eluted which are above 6 kDa and not of our interest. Frac-
tions corresponding to molecular weight of about 1.5 kDa 
were further purified using RP-HPLC. As the initial frac-
tions also showed activity, these may represent the aggre-
gated form of lipopeptide present in the sample.
Reverse Phase HPLC
Figure 3 shows the chromatogram of the HPLC purifica-
tion of samples obtained from TLC, SPE, and gel filtration. 
Four active fractions were observed at 75 % acetonitrile 
with retention time ranging from 8 to 11 min. However, 
maximum activity was observed in fraction corresponding 
to retention time 10 min. This fraction was further ana-
lyzed through Tricin PAGE and MALDI–TOF-MS for their 
molecular mass determination.
Tris‑Tricine SD‑PAGE
Tris-Tricine SDS was unable to discriminate between the 
lipopeptides produced by the strain BIA; however, it con-
firmed the purity of sample preparation. The purified prod-
uct was considerably smaller than the marker band with 
lowest molecular weight and is free of any contaminat-
ing material as evidenced by the lack of any other bands. 
As a comparison, the culture supernatant produced many 
bands of stained contaminated material. A direct activity 
assay confirmed that the purified product is about 3 kDa, 
as revealed by the zone of inhibition on test organism plate.
MALDI–TOF Mass Spectrometry
Purified product from RP-HPLC and whole bacterial cells 
were selected for analysis with MALDI–TOF-MS. When 
whole bacterial cells were used, these did not produce a 
good spectrum (data not shown). In the linear mode, we 
observed two clusters of peaks with different mass/charge 
(m/z) ratios for purified product (Fig. 4). One cluster was 
observed with m/z ratios between 1022 and 1036 which 
may be regarded as surfactin isoforms. The peak with a m/z 
ratio 1022.7 corresponds to the mass of [M + H]+ ion of 
surfactin with a fatty acid chain length of 14 carbon atoms. 
Other cluster was detected with mass/charge (m/z) ratios 
between 1070 and 1112.6, which could be attributed to pro-
tonated iturin isoforms. For example, the peak with a m/z of 
1070.6 corresponds to the mass of [M + H]+ ion of iturin 


















Fig. 2  Elution pattern of peptide antibiotic from a Bio-Gel P-10 col-
umn equilibrated in 50-mM Tris buffer, pH 7.5. Fractions were col-























Fig. 3  Purification of lipopeptides by reversed-phase HPLC on a 
Thermo Hypersil-Keystone ODS column. A segmented gradient was 
used and product eluted at 75 % of acetonitrile. Flow rate was main-
tained at 1 mL/min
Fig. 4  MALDI–TOF-MS analysis of surfactin and iturin like com-
pounds produced by B. subtilis strain BIA
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spectrometric analysis revealed that surfactin and iturin like 
compounds are produced by B. subtilis strain BIA.
Discussion
Lipopeptides produced by Bacillus subtilis are members of a 
particular antibiotic class that included surfactin, iturin, and 
fengycin families [27]. These are non-ribosomally gener-
ated peptides and the synthesis is directed by large multien-
zyme complexes that have a modular structural organization 
and are thought to orderly link the amino-acid residues of 
the final peptide [28]. These represent potent biosurfactants 
and show efficient antimicrobial and antiviral properties, 
and, thus, are valuable, industrially important compounds. 
Studying the HPLC analysis of the culture supernatants of 
seven Bacillus subtilis strains, Ahimou et al. [29] showed 
that lipopeptide profile varied greatly according to the strain. 
Coproduction of surfactin and iturin or plipastatin B1, an 
inhibitor of phospholipase A2 [30], has also been reported 
in some B. subtilis strains [31–33]. This paper describes the 
extraction and purification of lipopeptide antibiotics from 
a newly isolated B. subtilis BIA strain. Table 1 outlines the 
effectiveness of each purification protocol. On the basis of 
these results, acid precipitation of the culture supernatant 
followed by SPE, ethyl acetate extraction followed by TLC, 
and ammonium sulfate precipitation followed by gel filtra-
tion actually increased antibiotic activity relative to superna-
tant. SPE proved to be the optimum method of isolation, as it 
accomplished 20 % recovery of the initial antibiotic activity 
and increases specific activity to 7.3 fold over that of original 
sample. Gel filtration indicated that lipopeptides were eluted 
from the column in two different forms, that is, as a mono-
mer (MW ≤1200 Da) and as an aggregate (MW >6000 Da). 
Lipopeptides like surfactins have the ability to form micelle 
structures that form high-molecular weight aggregates. Mul-
ligan and Gibbs [15] took advantage of this property in a 
one-step method to purify and concentrate surfactin from the 
culture supernatant by ultrafiltration. The ability of surfactant 
molecules to form high-molecular aggregates allows them 
to be retained by relatively high-molecular weight cut-off 
membranes. HPLC purification provided a highly purified 
sample for molecular mass determination with an increase of 
specific activity to 10.69 fold. As previously reported [34], 
using whole-cell MALDI–TOF, mass spectrometry cellular 
products can be detected which either are attached to the 
cell surface or are integrated into the outer cell membrane. 
In this way, information on the secondary metabolites pro-
duced by a microorganism can be obtained in minutes with 
high precision and sensitivity with no need to fractionate and 
purify the detected compounds. However, in this study, we 
were not able to produce a good spectrum from the whole-
cell analysis. The purified product from RP-HPLC revealed 
that B. subtilis strain BIA produced a C14 surfactin and C16 
iturin like compounds based on their molecular masses. The 
co-production by this strain is an interesting characteristic 
with potential practical applications. Further characterization 
of these lipopeptides would have relevance to minimize the 
use of synthetic fungicides and surfactants.
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